LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
15.04
-0.97 (-6.06%)
At close: Oct 8, 2025, 4:00 PM EDT
15.04
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:10 PM EDT

LB Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
Net Income
-29.43-63.1-6.28-14.35
Depreciation & Amortization
0.240.0900
Other Amortization
3.223.223.881.64
Loss (Gain) From Sale of Investments
-1.22-0.990.1-0
Stock-Based Compensation
3.723.160.30.43
Other Operating Activities
-1.081.26-8.799.46
Change in Accounts Payable
-17.655.021.10.13
Change in Other Net Operating Assets
0.78-1.7-2.41-0.05
Operating Cash Flow
-41.43-53.05-12.09-2.73
Capital Expenditures
-0.69-0.77-0.03-
Investment in Securities
48.0924-27.990.12
Investing Cash Flow
47.423.23-28.010.12
Long-Term Debt Issued
--0.7325.01
Net Debt Issued (Repaid)
--0.7325.01
Issuance of Common Stock
0.020.020-
Other Financing Activities
--1.71-2.05-2.95
Financing Cash Flow
0.0238.3233.6822.96
Net Cash Flow
5.998.5-6.4320.36
Free Cash Flow
-42.13-53.82-12.12-2.73
Free Cash Flow Per Share
-167.31-213.75-48.55-11.80
Cash Interest Paid
--1.98-
Cash Income Tax Paid
0000
Levered Free Cash Flow
--28.34-6.09-
Unlevered Free Cash Flow
--28.34-6.96-
Change in Working Capital
-16.873.31-1.310.09
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q